APOE and Brain atrophy: In contrast, the APOE-ε4-positive MCI population already has significant pathological changes, such as structural brain atrophy or Aβ deposition, and the use of only single characteristic brain structures or CSF Aβ has been found to lead to a decreased sensitivity in predicting the progression of MCI to AD (Jack et al., 2010).